Sibutramine on Cardiovascular Outcome

Por Scheen, André J.
Publicado em 2011

Pharmacokinetic and Pharmacodynamic Profile of Empagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor

Por Scheen, André J.
Publicado em 2014

Towards a genotype-based approach for a patient-centered pharmacologic therapy of type 2 diabetes

Por Scheen, André J.
Publicado no Ann Transl Med (2015)

Pulsatile Stress in Middle-Aged Patients With Type 1 or Type 2 Diabetes Compared With Nondiabetic Control Subjects

Por Philips, Jean-Christophe, Marchand, Monique, Scheen, André J.
Publicado em 2010

Body image discrepancy and subjective norm as mediators and moderators of the relationship between body mass index and quality of life

Por Pétré, Benoit, Scheen, André J, Ziegler, Olivier, Donneau, Anne-Françoise, Dardenne, Nadia, Husson, Eddy, Albert, Adelin, Guillaume, Michèle
Publicado no Patient Prefer Adherence (2016)

Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion

Por Zannad, Faiez, Stough, Wendy Gattis, Lipicky, Raymond J., Tamargo, Juan, Bakris, George L., Borer, Jeffrey S., Alonso García, Maria de los Angeles, Hadjadj, Samy, Koenig, Wolfgang, Kupfer, Stuart, McCullough, Peter A., Mosenzon, Ofri, Pocock, Stuart, Scheen, André J., Sourij, Harald, Van der Schueren, Bart, Stahre, Christina, White, William B., Calvo, Gonzalo
Publicado no Eur Heart J Cardiovasc Pharmacother (2016)